What is Viemed Healthcare, Inc.'s market cap?

Viemed Healthcare, Inc. (VMD) has a market capitalization of $464.6M and trades on NASDAQ.

What is Viemed Healthcare, Inc.'s revenue and profitability?

Viemed Healthcare, Inc. generated $286.6M in trailing twelve-month revenue with net income of $14.9M, representing a net margin of 5.2%. Gross margin stands at 57.6%, with free cash flow of $25.9M. These figures are based on the Q1 2026 filing.

Who are Viemed Healthcare, Inc.'s competitors?

Viemed Healthcare, Inc.'s key competitors include AdaptHealth Corp., InfuSystem Holdings, Inc., ResMed Inc., and others. These companies compete in similar markets and product categories.

Who does Viemed Healthcare, Inc. partner with?

Viemed Healthcare, Inc.'s notable partners include Centers for Medicare & Medicaid Services, Regions Bank, Hancock Whitney Bank.

What subsidiaries does Viemed Healthcare, Inc. have?

Viemed Healthcare, Inc.'s subsidiaries include Lehan Drugs, Inc., East Alabama HomeMed, LLC.

Where is Viemed Healthcare, Inc. headquartered?

Viemed Healthcare, Inc. is headquartered in United States of America and employs approximately 1,030 people. It has been publicly traded since 2018.

Viemed Healthcare, Inc.

VMD

Viemed Healthcare is a leading provider of home medical equipment and post-acute healthcare services in the United States, specializing in high-touch respiratory care and chronic disease management.

Market cap

$464.64M+90.2%

Revenue$286.6M+23.1%

Net income$14.9M+21.2%

Free cash flow$25.9M+390%

EPS (diluted)$0.37+19.4%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 5, 2026

Revenue$75.4MBeat by $1.0M EPS$0.06Miss by $0.03

Read the full report

Next report

Aug 3, 2026 (In 5 days)

Revenue estimate$78.0M

EPS estimate$0.10

Financials

Q1 2026

Income statement

See full

Revenue$75.4M+27.5%

Gross profit$42.8M+28.7%

Operating income$4.3M+11.8%

Net income$2.6M-1.6%

EPS (diluted)$0.060.0%

Balance sheet

See full

Cash & equivalents$9.8M-3.9%

Total debt$12.4M+84.0%

Total equity$143.9M+6.8%

Total assets$197.4M+10.8%

Cash flow

See full

Operating cash flow$8.1M+183%

CapEx$6.7M-56.6%

Free cash flow$1.4M+111%

Valuation & ratios

Valuation

See full

Market cap$464.64M+90.2%

Enterprise value$467.32M+100%

P/E31.2×+13.6×

P/S1.6×+0.6×

Profitability

See full

Gross margin57.6%-1.1pp

Operating margin8.2%-0.2pp

Net margin5.2%-0.1pp

FCF margin9%—

Returns & leverage

See full

Return on equity10.7%+0.9pp

Debt / equity0.1×0.0×

Current ratio1.2×-0.2×

Segments

By product

See full

Equipment and supply sales$17.5M+133%

Service revenues$6.4M-1.9%

Competitors

By market cap

ResMed$29.5B-26.5%

BrightSpring Health Services, Inc.$14.1B+292%

Solventum$13.9B+9.2%

Merit Medical Systems$4.5B-9.1%

AdaptHealth$1.5B+15.2%

Viemed Healthcare, Inc.$464.6M+88.7%

InfuSystem Holdings$188.9M+52.6%

AMS

American Shared Hospital Services$10.2M-40.5%

By revenue growth

BrightSpring Health Services, Inc.+28.0%

Viemed Healthcare, Inc.+23.1%

Merit Medical Systems+11.1%

ResMed+10.3%

InfuSystem Holdings+3.5%

AdaptHealth+1.2%

Solventum-0.5%

By net margin

ResMed27.44%+1.3pp

Solventum17.33%+12.8pp

Merit Medical Systems9.03%+0.2pp

InfuSystem Holdings5.56%+3.2pp

Viemed Healthcare, Inc.5.2%-0.1pp

BrightSpring Health Services, Inc.2.27%+2.3pp

AdaptHealth-2.42%-5.0pp

Profile

Viemed Healthcare is a leading provider of home medical equipment and post-acute healthcare services in the United States, specializing in high-touch respiratory care and chronic disease management. The company utilizes a technology-enabled model where licensed clinical practitioners provide in-home therapy and counseling to improve patient outcomes and reduce hospital readmissions. Its core value proposition centers on delivering superior quality care at a lower total cost than traditional hospital settings.

Competitive position

Viemed is a leading provider of non-invasive ventilation services in the U.S., competing through a decentralized, personnel-heavy model that prioritizes clinical service over physical retail locations.

GeographiesUnited States

Customer segmentsChronic disease patients, Elderly population, Healthcare institutions, Maternal health patients

Business modelEquipment Rental, Direct-to-Consumer Sales, Professional Services, Staffing and Recruitment

SuppliersMedical equipment manufacturers, Respiratory device vendors, Logistics and transportation providers

CustomersMedicare, Medicaid, Commercial health insurers, Managed care organizations, Hospitals and clinics

CountryUnited States of America

Listed2018

Employees1.0K

CEOCasey Hoyt

SectorHealthcare

IndustryMedical - Devices

Websiteviemed.com

FilingsSEC EDGAR

Ask your AI about Viemed Healthcare, Inc..

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viemed Healthcare, Inc.'s market cap?: Viemed Healthcare, Inc. (VMD) has a market capitalization of $464.6M and trades on NASDAQ.
What is Viemed Healthcare, Inc.'s revenue and profitability?: Viemed Healthcare, Inc. generated $286.6M in trailing twelve-month revenue with net income of $14.9M, representing a net margin of 5.2%. Gross margin stands at 57.6%, with free cash flow of $25.9M. These figures are based on the Q1 2026 filing.
Who are Viemed Healthcare, Inc.'s competitors?: Viemed Healthcare, Inc.'s key competitors include AdaptHealth Corp., InfuSystem Holdings, Inc., ResMed Inc., and others. These companies compete in similar markets and product categories.
Who does Viemed Healthcare, Inc. partner with?: Viemed Healthcare, Inc.'s notable partners include Centers for Medicare & Medicaid Services, Regions Bank, Hancock Whitney Bank.
What subsidiaries does Viemed Healthcare, Inc. have?: Viemed Healthcare, Inc.'s subsidiaries include Lehan Drugs, Inc., East Alabama HomeMed, LLC.
Where is Viemed Healthcare, Inc. headquartered?: Viemed Healthcare, Inc. is headquartered in United States of America and employs approximately 1,030 people. It has been publicly traded since 2018.